Pays: Irlande
Langue: anglais
Source: HPRA (Health Products Regulatory Authority)
Canine parvovirus
Merial Animal Health Limited
QI07AD01
Canine parvovirus
.
Lyophilisate for suspension
POM: Prescription Only Medicine as defined in relevant national legislation
Dogs
canine parvovirus
Immunological - Live Vaccine
Authorised
2004-11-03
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Eurican P. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 1 ml dose of vaccine contains: Freeze-dried pellet: Attenuated canine parvovirus >10 4.9 CCID 50 Excipients q.s. 1 dose For full list of excipients, see section 6.1. CCID 50 = 50% cell culture infective dose. 3 PHARMACEUTICAL FORM Lyophilisate for suspension. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs and puppies from 8 weeks of age. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Active immunisation of dogs from 8 weeks of age to prevent clinical signs and to reduce mortality and viral excretion caused by canine parvovirosis infection. Onset of immunity: 7 days after primary vaccination Duration of immunity: 2 years. 4.3 CONTRAINDICATIONS None. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. I R I S H M E D I C I N E S B O A R D ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _2_ _5_ _/_ _0_ _5_ _/_ _2_ _0_ _1_ _2_ _C_ _R_ _N_ _ _ _7_ _0_ _1_ _2_ _3_ _5_ _4_ _p_ _a_ _g_ _e_ _ _ _n_ _u_ _m_ _b_ _e_ _r_ _:_ _ _ _1_ 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS: The CPV vaccine strain of Eurican P may be shed from vaccinated animals for a number of days following vaccination. However, due to the absence of pathogenicity of the strain, it is not necessary to keep vaccinated animals separated from non-vaccinated animals. SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS: In the case of accidental self injection, seek medical Lire le document complet